trump executive order on glp 1 Questions swirl after Trump's GLP-1 pricing deal announcement White House launches discount drug
Description
Immunology drugs are still profitable
There are currently two major players with a decisive head start in the obesity drug space: Eli Lilly (LLY) and Novo Nordisk (NVO)
In this article, we explore the role and therapeutic potential of these well-established obesity drug targets
If you're on a GLP-1, creatine might be the supplement you're missing
